{{item.desc}}
Scientists discover blood sample detection method for multiple sclerosis, the process will avoid invasive, painful process of collecting fluid from brain and spine
A method for quickly detecting signs of multiple sclerosis has been developed by a University of Huddersfield research team.
University of Huddersfield researchers have developed a blood test for diagnosing Multiple Sclerosis that avoids the invasive, painful process of collecting fluid from the brain and spine.
European Lead Factory (ELF) project has identified novel small molecules that might be transformed into a new medical treatment for depression and pain.
Having discovered an interesting protein involved in depression and pain, Dr Patrick McHugh, University of Huddersfield, wanted to access chemical tools to further explore its role and action.
Pioneering ideas to improve antidepressant therapies are greatly required since existing antidepressants are moderately effective and the response rate in patients suffering from depression is approximately less than 50%.
Exciting new hits for a novel drug target involved in depression and pain unveiled in the ELF
Exciting new hits for a novel drug target involved in depression and pain unveiled in the EU Lead Factory
Drugs researchers have launched a £1 million project at the University of Huddersfield. The new Centre for Biomarker Research (CeBioR) aims to speed up the development of new drugs for a range of conditions and diseases.
SCIENTISTS at the University of Huddersfield led by Dr Patrick McHugh (pictured right) have embarked on a project that could lead to a more effective treatment for depression.
New £1 million research centre up and running to create drugs for cancer, dementia and chronic pain
Matched funding enables the University of Huddersfield to create the Centre for Biomarker Research
New Centre for Biomarker Research Launched at the University of Huddersfield
Effects of different isoforms of apoE on aggregation of the α‐synuclein protein implicated in Parkinson’s disease
Dr Patrick McHugh joins team working on the potential role that alpha-synuclein protein plays in Parkinson’s disease
‘Researchers wish to hear from people over the age of 18 who DO NOT suffer from chronic pain (> 3 months) to comprise a control group for a research project’
“...pain is a highly subjective phenomenon and sensitivities vary from patient to patient...”
University scientist Dr Patrick McHugh is on a mission to help doctors treat one of the least understood but most widespread causes of suffering
